B.L. Guthrie

Shortwave infrared fluorescence imaging with the clinically approved near-infrared dye indocyanine green

IDH1andIDH2Mutations in Gliomas

Malignant astrocytic glioma: genetics, biology, and paths to treatment

Nanomedicine for drug targeting: strategies beyond the enhanced permeability and retention effect

Molecularly targeted therapy for malignant glioma

Designing antimicrobial peptides: form follows function

Advances and Challenges of Liposome Assisted Drug Delivery

CSF-1R inhibition alters macrophage polarization and blocks glioma progression

Malignant Gliomas in Adults

Inhibiting kinases in malignant gliomas

The use of fluorescent dyes and probes in surgical oncology

Honokiol: A Novel Natural Agent for Cancer Prevention and Therapy

Diagnosis and Treatment of High-Grade Astrocytoma

Design and Development of Peptides and Peptide Mimetics as Antagonists for Therapeutic Intervention

Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group

Phase I Single-Dose Study of Intracavitary-Administered Iodine-131-TM-601 in Adults With Recurrent High-Grade Glioma